Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 2, 2011

Inflammatory markers in preeclamptic patients

  • Murat Can EMAIL logo , Eray Sancar , Muge Harma , Berrak Guven , Gorkem Mungan and Serefden Acikgoz

Abstract

Background: Preeclampsia is characterized by hypertension and proteinuria that begins in the second half of pregnancy. Endothelial dysfunction and trophoblastic hypoperfusion seen in preeclampsia suggested to be part of an increased maternal inflammatory response to pregnancy. In this study, we aimed to evaluate some inflammatory markers in pre-eclamptic and normotensive pregnants.

Methods: The study included 36 cases with mild preeclamp-sia, 36 cases with severe preeclampsia and 33 cases of normotensive pregnant. High sensitive C-reactive protein (hsCRP) and serum amyloid A (SAA) were measured by enzyme-linked immunosorbent assays, serum procalcitonin was measured by enzyme-linked fluorescent immunassay. Mean arterial pressure (MAP) was used as an indicator of the severity of the disease.

Results: In severe preeclampsia group hsCRP, serum amyloid A and procalcitonin levels were significantly higher than mild preeclamptic and normotensive groups. SAA and hsCRP levels were higher in mild preeclamptic group when compared with normotensive pregnant but no significant difference was found in procalcitonin between these groups. There were significant correlations betweeen hsCRP, SAA, procalcitonin and MAP.

Conclusions: The results confirm that inflammatory reactions are closely associated with preeclampsia.


Corresponding author: Murat Can, Department of Biochemistry, Karaelmas University of Medicine, Zonguldak, Turkey Phone: +90-372-2612839, Fax: +90-372-2610155

Received: 2011-1-4
Accepted: 2011-4-1
Published Online: 2011-06-2
Published in Print: 2011-09-01

©2011 by Walter de Gruyter Berlin Boston

Downloaded on 19.4.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2011.232/html
Scroll to top button